CDC backs Pfizer COVID-19 vaccine booster shots for millions
The CDC director defended the decision, after differing on one key point with a panel of vaccine advisers
Watch CBS News
The CDC director defended the decision, after differing on one key point with a panel of vaccine advisers
As more U.S. businesses require employees to be vaccinated, many Americans are now seeking medical exemptions. CBS News' Megan Cerullo joins Lana Zak on CBSN to discuss what kind of health condition could excuse an individual from getting the COVID-19 vaccine.
CDC advisers voted to allow Pfizer's COVID booster shot for people 65 and older and others who are at high risk. Omar Villafranca has more.
The Food and Drug Administration authorized expanded access to booster shots of Pfizer's COVID-19 vaccine for people aged 65 and up as well as those with weakened immune systems and adults whose job or living situation frequently exposes them to the virus. It's now up to the Centers for Disease Control and Prevention to decide how and when the shots will be distributed. CBS News' Bradley Blackburn joins CBSN AM to discuss.
The Food and Drug Administration granted emergency-use authorization for booster shots of Pfizer's COVID-19 vaccine for seniors and other people considered to be high-risk, a scaled-down version of President Biden's original plan for the additional shots. Meanwhile, Mr. Biden met with Democratic lawmakers on a $3.5 trillion spending bill. CBS News senior White House correspondent Weijia Jiang joins CBSN AM with more.
Dr. Ogechika Alozie, an infectious disease specialist in Texas, joins CBSN to discuss FDA authorization of Pfizer's vaccine booster shot for people age 65 and up or at higher risk from COVID-19. He also discusses the benefits of vaccination for pregnant people and the high rate of COVID-19 in Texas.
Health insurers — which once waived costs of treating COVID-19 — are increasingly asking patients to chip in.
Third doses could roll out this week, pending a review by CDC advisers
Valid medical conditions that might excuse someone are "very, very rare -- like one in a million," one disease expert said.
The FDA authorized Pfizer's coronavirus vaccine booster shot for those who are high-risk or aged 65 and older. It comes as the Delta variant surge appears to be peaking nationally, according to researchers advising the CDC. Nancy Chen has the latest.
Pregnant women who contract COVID-19 are at an increased risk of severe complications and death, according to the CDC. Yet many are unvaccinated. Mireya Villarreal reports.
Doctors fear flu cases will surge this fall and winter as coronavirus restrictions ease and COVID patients continue to fill hospitals, creating a "twindemic." Dr. Jen Caudle, an associate professor in the department of family medicine at Rowan University, joins CBSN's Tanya Rivero to discuss what to expect.
But the message being driven around uptown Charlotte during the Panthers game wasn't anti-vaccine at all. Quite the opposite. And it had tongues wagging and social media stirring.
Johnson & Johnson said a second dose of its one-shot COVID vaccine offers stronger protection against the disease. Mark Strassmann has the latest.
The number of reported deaths in the U.S. linked to COVID-19 has surpassed 676,000, according to Johns Hopkins University. The death toll now exceeds the number of Americans believed to have died during the Spanish flu pandemic in 1918. Infectious disease expert Dr. Amesh Adalja joined CBSN to discuss.
The company says it will seek U.S. approval for that age group soon. One board member says if all goes well, the green light could come "as early as around Halloween."
Pfizer said its COVID vaccine is safe and effective at a lower dose for children 5 to 11 years old. The company is hoping the shots will be available by the end of October. Mola Lenghi reports.
Pfizer says a smaller dose of its COVID-19 vaccine is safe and effective in children ages 5 to 11. The company will submit its findings to the FDA for review. CBS News correspondent Mola Lenghi reports on the details, and then pediatrician Dr. Rashmi Jain joins CBSN to discuss what it will mean for families.
President Biden’s plan to give booster shots to most Americans was rejected by an FDA advisory panel just days before its rollout. The panel did, however, endorse a Pfizer booster shot for older Americans or those at risk of serious disease. Jonathan Vigliotti has the latest.
Pfizer has announced its COVID-19 vaccine showed promising results in children ages 5 to 11 years old. CBS News' Mola Lenghi spoke with one family who was part of the trials, then Dr. Ron Elfenbein joins CBSN AM to talk more about the research and when the vaccine could be available for younger age groups.
In this extended version of an interview that aired on Sunday, September 19, 2021, Dr. Scott Gottlieb discusses the missteps of the U.S. response to the pandemic and his new book, "Uncontrolled Spread: Why COVID-19 Crushed Us and How We Can Defeat the Next Pandemic."
When can kids get vaccinated? Are Delta variant symptoms worse?
In this extended version of an interview that aired on Sunday, September 19, 2021, Dr. Scott Gottlieb discusses the missteps of the U.S. response to the pandemic and his new book, "Uncontrolled Spread: Why COVID-19 Crushed Us and How We Can Defeat the Next Pandemic."
The debate over the necessity of COVID-19 booster shots is becoming yet another point of contention in public health discourse. Meanwhile, there are signs of hope as the U.S. reported two straight weeks of decline in new infections. Anthony Pura reports.
United Airlines CEO Scott Kirby says he expects business travel to begin to recover in January.